[MRSA].
Hanaki
H
H
Department of Bacteriology, Juntendo University School of Medicine.
D000617:Aminoglycosides; D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology / Q000627:therapeutic use; D000891:Anti-Infective Agents, Local / Q000494:pharmacology / Q000627:therapeutic use; D001426:Bacterial Proteins; D001427:Bacterial Toxins; D003982:Dibekacin / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D004768:Enterotoxins / Q000037:antagonists & inhibitors / Q000096:biosynthesis; D005840:Gentian Violet / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000494:pharmacology / Q000627:therapeutic use; D016106:Methicillin Resistance / Q000235:genetics; D012097:Repressor Proteins; D013203:Staphylococcal Infections / Q000188:drug therapy / Q000382:microbiology; D013211:Staphylococcus aureus / Q000187:drug effects / Q000235:genetics; D018089:Superantigens; D017334:Teicoplanin / Q000494:pharmacology / Q000627:therapeutic use; D014640:Vancomycin / Q000494:pharmacology / Q000627:therapeutic use
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D000891:Anti-Infective Agents, Local; D001426:Bacterial Proteins; D001427:Bacterial Toxins; D004768:Enterotoxins; D016756:Immunoglobulins, Intravenous; C101640:MecI protein, Staphylococcus; D012097:Repressor Proteins; D018089:Superantigens; C030107:enterotoxin F, Staphylococcal; D003982:Dibekacin; D017334:Teicoplanin; D014640:Vancomycin; C031986:arbekacin; D005840:Gentian Violet